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ABSTRACT 
Objective: Plant–derived male antifertility agents need to address the basic requirements of fertility suppression without affecting libido. This 
study was undertaken to evaluate the male antifertility potential of the β-sitosterol (BS) which is an active component isolated from the methanolic 
root extract of Barleria prionitis in the male albino rats. 
Methods: β-sitosterol was extracted using silica gel column chromatography from the methanolic root extract of Barleria prionitis and 
characterized by IR and NMR spectral analysis. Extracted BS was further used to determine its antifertility activity. The rats were orally 
administered olive oil (Group-I, control), BS at the dose level of 5 (Group II), 15 (Group III) and 25 mg/kg body weight (Group IV) for 60 d. Body 
weight was measured weekly. At the end of the experimental duration, treated males were sacrificed and subjected to biochemical, hormonal and 
sperm analysis. Fertility was assessed by mating treated rats with normally cycling virgin females. 
Results: Average weight of reproductive organs, serum levels of Testosterone, Follicular stimulating hormone (FSH) and Luteinizing hormone (LH), 
levels of Protein, Ascorbic acid, Glycogen, Fructose, sperm motility and sperm density was decreased significantly as compared to control group. 
While, Cholesterol level was increased significantly. Fertility percentage was also decreased in treated groups. Body weight remained unchanged. 
Conclusion: The results show that β-sitosterol from the roots of Barleria prionitis causes suppression of spermatogenesis and fertility thereby 
suggesting the potential of β-sitosterol for the development of male contraceptive which has very limited options available. 
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INTRODUCTION 
The future of life on the planet is under the pressure of the 
population explosion, which is a major cause of pollution and 
poverty, dwelling especially in the developing countries [1]. Fertility 
regulation has, thus, become the major concern of people of all walks 
of life. Contraceptive methods can be applied to prevent unwanted 
pregnancies either temporarily or permanently. The development of 
new and improved contraceptive agent for men has lagged far 
behind than the development of female birth control devices. The 
male reproductive system, especially the process of 
spermatogenesis, sperm development, transport and the sperm-egg 
interaction is thus complex that it delivers not so far been possible 
to obtain an efficacious intervention for fertility control [2]. Hence, 
in that respect is a clear demand for the research and development 
of novel and improved medical contraceptive methods for men that 
satisfy the substantive standards of safety, efficacy, economy and no 
side effects [3].  
Plants play a significant part in fertility regulation. Plants can act as 
antifertility agents; these include antispermatogenic plants, 
spermicidal, semen coagulant and fertility inhibiting plants. [4, 5]. In 
the recent past, a number of plants have been keyed out, and 
evaluation of extracts and active principles from different divisions 
of plants like seeds, stem, leaves, flowers, root or stem barks has 
been performed by several researchers. A number of plants have 
been screened for the growth of an effective agent to determine 
male fertility [6]. One advantage of getting a male antifertility agent 
from a plant origin, rather than through the complete synthesis of 
fresh drugs, is that a plant used as a prophylactic agent in an 
indigenous medical system is probably to take in a long 
ethnobotanical history and established low toxicity potential. 
Although hormones or hormone antagonists have been employed 
for regulating male fertility, they also exert their effects on non-
reproductive tissues. Thus, it would be of great interest to develop 
fertility inhibitors that are completely selective for the reproductive 
system and enzymes, and it is possible that a plant-derived drug may 
induce this issue. 
Among several medicinal plants, Barleria prionitis (B. prionitis) L. of 
Acanthaceae family is significant and clearly accepted herb 
possessing healing & curative qualities. It is commonly known as 
Porcupine flower, Barleria, Kundan, Mullu guarantee, 
Pilikantashelio, etc. The flora is especially well recognized for caring 
for bleeding gums and toothache. Because of its anti odontalgic 
property, it is also recognized as ‘Vajradanti’ [7]. The whole plant or 
its specific parts (leaf, stem, root, bark and flower) have been 
utilized for the treatment of catarrhal affections [8], ulcer, whooping 
cough, inflammations, glandular swellings, urinary infection, 
jaundice, fever, stomach disorders and as diuretic and tonic. Extracts 
and isolated phytochemicals from this plant have been found to have 
a wide scope of pharmacological activities like antimicrobial [9], 
Anti-nociceptive [10], antispermatogenic [11], antihelmintic, 
antioxidant [12], antidiabetic [13], anti-inflammatory [14], anti-
arthritic, cytoprotective, hepatoprotective [15], diuretic, 
antidiarrheal, and enzyme inhibitory activities without any toxic 
effects [16]. The aqueous bioactive fractions are reported to possess 
hepatoprotective, antistress, and immuno restorative properties 
[17]. Male rats treated with isolated fractions of the B. prionitis root 
methanolic extract (100 mg/kg for 60 d) showed a significant 
reduction in spermatogenesis without affecting general body 
metabolism. Sperm motility as well density in cauda epididymides 
was reduced significantly. The population of various spermatogenic 
cells, such as primary spermatocytes, secondary spermatocytes, and 
round spermatids was declined significantly in treated animals [18]. 
This tempted us to isolate the active component from B. prionitis and 
to determine whether it can be responsible for its antifertility 
activity in male rats.  
Therefore, the objective of this study was to identify  and  
characterize the bioactive principle from the roots of B. prionitis and 
determine its antifertility activity in male rats. Herein we reported 
the isolation of β-sitosterol (BS) from the roots of B. prionitis which 
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is one of the most ubiquitous substances in plant extracts [19]. 
Scientific research has proven that β-sitosterol is a safe and nontoxic 
plant nutrient for maintaining health and for protection against 
many serious health disorders and diseases. β-sitosterol posse’s 
genotoxicity effect [20], antidiabetic [21-23], antibacterial [24], 
antimicrobial [25], antihelminthic and antimutagenic [26] activities. 
It is also utilized for the Prostatic cancer treatment [27, 28]. Since β-
sitosterol has been isolated and characterized from the medicinal 
plant i.e. B. prionitis. In future, these chemical entities can be 
extracted and synthesized herbally according to their structural and 
functional activity and considered for the development of new drugs 
in clinical trial studies. 
MATERIALS AND METHODS 
Collection and authentication of the plant material 
The plant material (root part) of Barleria prionitis was collected 
from the hilly area of Ajmer, Rajasthan. The plant was taxonomically 
identified and authenticated by the Department of Botany, 
University of Rajasthan, Jaipur. (RUBL NO. 211575). A Voucher 
specimen was preserved in the reproductive physiology laboratory, 
Department of Zoology, University of Rajasthan, Jaipur for further 
verification. 
Extraction and isolation of the compound 
The shade dried plant material (1.5 kg) was finely powdered and 
extracted with methanol in a 5 liter round bottom flask for 72 h on a 
water bath. The extract was filtered hot and the solvent was 
removed by distillation under reduced pressure where a semi-solid 
dark gray mass (27 g) was obtained. The solvent free extract was 
chromatographed over silica gel column built in petroleum ether 
and eluted with increasing amounts of benzene followed by eluting 
with benzene. Elutes of 200 ml were collected each time, and the 
solvent was distilled on a water bath. The homogeneity of the 
fractions was examined by TLC on silica gel plates. The spots 
developed were visualized under UV light and then by exposure to 
iodine vapor. Similar fractions were combined and purified. 
Fractions eluted with petroleum ether-benzene mixture (80:20) 
yielded a white solid with a Rf value of 0.47 on TLC in petroleum 
ether-benzene (4:1). The structure of the isolated compound was 
established on the basis of elemental analysis and spectroscopic 
evidence (IR, UV, 1HNMR, 13CNMR, MS). 
Test for alcohol 
Four grams of Ceric ammonium nitrate were dissolved in 10 ml of 2 
N HNO3, on mild heating. A few crystals of the compound were 
dissolved in 0.5 ml of dioxane. The solution was added to 0.5 ml of 
Ceric ammonium nitrate reagent and diluted to 1 ml with dioxane 
and shaken well. The compound developed yellow to red color 
indicating the presence of an alcoholic hydroxyl group [28]. 
Test for steroid 
Salkowski reaction 
A few crystals of the compound were dissolved in chloroform, and a 
few drops of concentrated sulphuric acid were added to the solution, 
a reddish color in the upper chloroform layer was formed [28] 
indicating the presence of steroids. 
Liebermann-burchard reaction 
A few crystals of the compound were dissolved in chloroform, and a 
few drops of concentrated sulfuric acid were added to it followed by 
the addition of 2-3 drops of acetic anhydride. In this case, the color 
of the compound turned to violet blue and finally formed a green 
color which indicates the presence of steroids [28]. 
General experimental procedures 
Melting points were determined in soft glass capillaries in an 
electrothermal melting point apparatus. Qualitative TLC was 
conducted on aluminum sheet Kieselgel 60 F254 (E. Merck). Silica 
gel (E. Merck, 60-120 mesh, 550 g) used for column (1.5 m × 4.0 cm) 
chromatography. The IR spectra were recorded on FTIR SHIMADZU 
8400S spectrometer with KBr pellets. The 1H and [13]C NMR spectra 
were recorded in CDCl3 at 400 MHz and 100 MHz on a JEOL NMR 
instrument, respectively, using TMS as the internal standard. FAB 
mass spectra were recorded on JEOL SX 102/DA-6000 mass 
spectrometer using Argon/Xenon as FAB gas. 
Animals 
Healthy and fertile male albino rats (Body weight: 150 to 200 g) of 
“Wistar strain” were used for the present investigation. All animals 
were housed in the Animal room with alternating 12 hr. light and 
dark periods and controlled constant temperature and humidity. 
The animals were given routine laboratory feed and water ad 
libitum. All animal experiments were performed according to ethical 
guidelines suggested by the Committee for the Purpose of Control 
and Supervision of experiments on animals (CPCSEA), Ministry of 
Environment and Forest, Government of India (1678/GO/ 
a/12/CPCSEA Dated 09-01-2013). 
Determination of LD50 
The LD50 was determined using the fixed-dose procedure by Walum 
[29]. Briefly, BS was given at one of the four fixed doses (5, 50, 100, 
2000 mg/kg BW) at a time to 5 male Wistar rats. The LD50 value of 
BS was found to be 105 mg⁄ kg body weight (BW). On the basis of 
these experiments, three doses of BS (i.e. 5, 15 and 25 mg⁄ kg BW 
per day) were used in subsequent experiments. 
Experimental design 
Animals were kept for 7 d for acclimatization prior to the 
experiment. 
After 15 d of acclimatization, they were randomly divided into 4 
groups of 5 animals in each group. The daily dose of the compound 
was prepared and administered to each animal for 60 d. The 
treatment schedule of each group was as follows:  
Group I: Animals of this group received 0.5 ml of olive oil/day for 60 
d. (Vehicle-treated control) 
Group II: Rats received BS in a dose of 5 mg/kg body weight daily for 
60 d (low dose). 
Group III: Rats received BS in a dose of 15 mg/kg body weight daily 
for 60 d (moderate dose). 
Group IV: Rats received BS in a dose of 25 mg/kg body weight daily 
for 60 d (High dose). 
Fertility test 
The fertility of each male rat was assessed by natural mating with 
two estrous females before and after five days of the treatment. The 
vaginal plug and presence of sperms in the vaginal smear were 
checked for positive mating. The mated females were allowed to 
complete the gestation period. Then fertility percentage according to 
the number of females got pregnant from the number of females 
mated, was calculated and compared with control.  
Autopsy scheduled 
After 24 h of last treatment, the final weight was recorded, and the 
animals were sacrificed using mild ether anesthesia. Blood was 
collected directly from the heart. Serum was separated by 
centrifugation at 3000 rpm for 10 min and stored at-20 °C until used 
for various biochemical assays. Then Testes, Epididymis, Vas 
deferens, Seminal Vesicle and Ventral prostate were dissected out, 
trimmed of extraneous and weighed accurately on a torsion balance.  
Body and reproductive organ weight 
From one side of the body part, reproductive organs were fixed in 
Bouin’s fixative for microtomy and the other side of the body part, 
reproductive organs (Testes, Epididymis, Vas deferens, Seminal 
vesicle and Ventral prostate) were maintained in-20 oC for 
biochemical studies. 
Sperm counts and motility 
Cauda epididymis was removed from each rat and quickly 
punctured with a disposable needle to obtain sperms. One hundred 
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mg of each tissue was homogenized in 1 ml saline solution and 
filtered through muslin cloth. The filtrate was used up in a leukocyte 
pipette up to 0.5 and get up to the mark 11 with buffered saline. 
Then a drop of this filtrate was transferred to the Neubauer counting 
chamber (hemocytometer) beneath a coverslip. The sperms were 
counted in the five random fields according to the method [30]. The 
percentage motility was determined by counting both motile and 
immotile spermatozoa per unit area [30]. 
Biochemical parameters 
Protein, glycogen, fructose, cholesterol, ascorbic acid was estimated 
in reproductive tissues. 
Blood and serum analysis 
Blood was collected, and the values of R. B. C., and W. B. C. counts, 
hematocrit, hemoglobin% and blood sugar were estimated. The 
serum was separated by centrifuging the blood at 3000 rpm. Total 
protein, cholesterol, HDL-Cholesterol, triglycerides and 
phospholipids, bilirubin, creatinine, SGOT, SGPT, alkaline 
phosphatase were estimated in serum according to the standard 
methods.  
Hormonal assay 
Serum was also analyzed for the estimation of testosterone, 
Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH). 
The quantitative determination of hormones was done by using the 
Enzyme Immunoassay Method (EIA). 
Statistical analysis 
The results were expressed as mean±SEM (Standard error of mean). 
The treated groups were compared to control using the Student's t-
test. *p ≤ 0.05 and **p ≤ 0.01 was regarded as significant while ***p 
≤ 0.001 was regarded as highly significant. 
RESULTS 
Physical and spectral analysis of β-sitosterol 
The compound is a white needle-shaped crystal with melting point 
138-140 °C which gave positive Salkowski and Lieberman-Burchard 
test for the steroid. Based on its spectral data (fig. 1, fig. 2) and 
physical properties, the compound was identified as the known 
compound β-sitosterol, and its structure is given in fig. 3. 
 
Spectroscopic data of isolated β-sitosterol from methanolic root extract of Barleria prionitis 
MS (m/z) : 414 (M+), 397, 383, 369, 255 etc.  
Molecular formula calculated as : C29H50O 
IR (KBr, Cm–1) : 3500-3445 (O–H stretching), 1590 (C=C stretching), 1050 (C-O stretching)  
1H NMR (δ 
ppm, CDCl3) 
: 3.52 (m, 1H, H-3), 5.30 (t, 1H, H-6), 0.65 (s, 3H, H-18), 0.99 (s, 3H, H-19), 1.25 (d, 3H, H-21), 0.84 (d, 3H, H-26), 0.92 (d, 3H, H-27), 




: 31.30 (C-1), 32.00 (C-2), 72.00 (C-3), 42.20 (C-4), 140.01 (C-5), 122.14 (C-6), 32.02 (C-7), 46.11 (C-8), 49.80 (C-9), 36.12 (C-10), 
20.98 (C-11), 28.20 (C-12), 42.34 (C-13), 57.00 (C-14), 24.32 (C-15), 40.12 (C-16), 56.20 (C-17), 12.00 (C-18), 19.50 (C-19), 
36.20 (C-20), 19.50 (C-21), 36.15 (C-22), 24.67 (C-23), 39.90 (C-24), 36.00 (C-25), 23.40 (C-26), 23.41 (C-27), 32.20 (C-28), 
29.45 (C-29)  
 
 
Fig. 1: 1H-NMR spectra of β-sitosterol 
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Fig. 3: Structure of β-sitosterol isolated from B. prionitis 
methanolic root extract 
Body and organ weight 
Non-significant changes in the body weight were observed in β-
sitosterol treated groups when compared to the control group 
(table1). The weight of Testes, Epididymis, Seminal vesicle, Ventral 
prostate and Vas deferens was found to be significantly decreased in 
treated male rats when compared with the weight of the same 
organs obtained from control rats. (table 1). 
The reduction was significant at p<0.01 in group II, but highly 
significant p<0.001 in group III and IV. While, the weight of vital 
organs i.e. Liver, Kidney, Heart, Adrenal gland showed non-
significant changes as compared to control. 
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Duration: 60 d; Values are±SEM; five animals were maintained in each group, Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
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Daily oral administration of 25 mg/kg BW (Group IV) for 40 d 
caused 100% inhibition of fertility, whereas, in the case of group II 
and III animals, the treatment caused 60% and 30% inhibition of 
fertility respectively when compared to the control (table 2).  
 





 No. of mated 
male/females 
(1:2) 







 Olive oil 
(Control) 
 5/10  10  100 
 Group 
II 
 BS 5 
mg/kg 
 5/10  6  60 
 Group 
III 
 BS 15 
mg/kg 
 5/10  3  30 
 Group 
IV 
 BS 25 
mg/kg 
 5/10  0  0 
 
Reproductive hormone profile 
Serum testosterone level 
BS (5, 15, 25 mg/kg body weight) repeated treatment daily for 60 d 
caused a significant decrease in the serum level of testosterone in 
male rats. The level of testosterone decrease was dose related (table 
3). It was reduced significantly p<0.01 in group II and III, while 
highly significantly p<0.001 in group IV compared to group I. 
Serum luteinizing hormone (LH) level 
Repeated treatment of male rats with the BS for 60 d caused a 
dose-related decrease in the serum level of LH (table 3). The 
level of decrease was statistically significant in group II 
(p<0.05), group III (p<0.01) and highly significant in group IV 
(p<0.001). 
Serum follicular stimulating hormone (FSH) level 
The level of serum FSH was significantly decreased (p<0.01) in rats 
treated with BS isolated from the roots of B. prionitis in group II, III 
and highly significantly (p<0.001) in group IV. (table 3). 
Sperm motility and sperm density 
Sperm motility and sperm density in cauda Epididymis significantly 
decreased, and the reduction was highly significant in higher dose 
treated (Group-IV) p<0.001, followed by moderate dose treated 
(Group-III) p<0.01 and low dose treated (Group-II) p<0.05, 
compared to control group (table 3). 
Tissue biochemical studies 
Glycogen 
The glycogen content of the testes, epididymis and vas deferens was 
highly significantly (p<0.001) decreased in group IV and 
significantly in group II (p<0.05) and III (p<0.01).  
The glycogen content in liver and heart was non-significantly 
changed in the treated group of rats as compared to control rats. 
(Group I). (fig. 4). 
 
Table 3: Effect of β-sitosterol on sperm motility, sperm density, and hormonal level 
Groups Treatment  Testosterone (ng/ml)  FSH (mIU/ml)  LH (mIU/ml)  Sperm motility % Sperm density 
(Millions/ml) 
Group I Olive oil (Control) 8.92±0.19 1.51±0.29 3.45±0.20 79.41±2.35  33.70±1.63 
Group II BS 5 mg/kg 6.23*±0.45 1.12*±0.54 2.67*±0.08  69.32*±7.67  28.65*±2.90 
Group III BS 15 mg/kg 5.87**±0.56 0.87**±0.04 1.89**±0.29  42.91**±7.85  20.30**±2.75 
Group IV BS 25 mg/kg 3.43***±0.36 0.23***±0.38 1.12***±0.01  29.07***±2.39  13.96***±1.99 
Duration: 60 d; Values are±SEM; five animals were maintained in each group, Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
 
 
Fig. 4: Impact of β-sitosterol treatment on glycogen levels in 
male rats 
 
Duration: 60 d; Values are±SEM; five animals were maintained in 
each group 
Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
Cholesterol 
In the animals of group II and group III the cholesterol value in the 
testis and epididymis showed a statistically significant increase at 
the significance level of (P<0.05) and (P<0.01) respectively, when 
compared to the control group. While in group IV highly significant 
(p<0.001) elevation was observed. The cholesterol content of liver 
and heart showed non-significant changes as compared to control 
rats. (fig. 5). 
 
 
Fig. 5: Impact of β-sitosterol treatment on Cholesterol levels in 
male rats 
 
Duration: 60 d; Values are±SEM; five animals were maintained in 
each group 
Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
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There was a significant decrease in the protein content of all 
reproductive organs due to 5 (p<0.05) and 15 mg/kg (p<0.01) 
treatment of β-sitosterol from B. prionitis roots, but it is highly 
significant (p<0.001) due to administration of 25 mg/kg BW dose 
level as compared to control animals. (fig. 6). 
 
 
Fig. 6: Impact of β-sitosterol treatment on Protein levels in male 
rats 
Duration: 60 d; Values are±SEM; five animals were maintained in 
each group 
Level of significance-*p<0.05, **p<0.01, ***p<0.001, when compared 
to control 
 
Total ascorbic acid (TAA) 
Highly significant (p<0.001), significant (P<0.01), (p<0.05) 
reduction was observed in the ascorbic acid content in the adrenal 
gland, after β-sitosterol treatment at the dose level of 5, 15 and 25 
mg/kg BW respectively. (fig. 7). 
Fructose 
Highly significant (p<0.001) decline in seminal vesicular fructose in 
group IV was observed in β-sitosterol isolated from B. prionitis 
treated rats while a significant decrease in group III (P<0.01) and 
group II (p<0.05) was evaluated. (fig. 7). 
 
 
Fig. 7: Impact of β-sitosterol treatment on protein levels in male 
rats 
Duration: 60 d; Values are±SEM; five animals were maintained in 
each group 
Level of significance-*p<0.05, **p<0.01, ***p<0.001, when compared 
to control 
 
Blood and serum biochemistry 
RBC, WBC, hemoglobin, hematocrit, Blood sugar, and Blood urea, 
were found to be within the normal range (table-4). Serum protein, 
cholesterol, triglycerides, phospholipids, bilirubin, SGOT, SGPT, 
alkaline phosphatase, acid phosphatase, were within the normal 
range throughout the study period. (table 5). 
 
Table 4: Effect of β-sitosterol on hematology, blood Urea, and blood sugar 
Groups Treatment  Hb 
(g/dl) 
Hematocrit PCV %  R. B. C 
(million/mm3) 
 W. B. C. 
(million/mm3) 
 Blood Sugar 
(mg/100 ml) 
 Blood Urea 
(mg/100 ml) 
 Group I  Olive oil (Control)  12.38±0.92  39.67±2.32  6.20±0.30  7560±23.39  87.92±1.98  26.92±1.89 
 Group II  BS 5 mg/kg  12.98ns±0.32  33.31ns±2.78  6.89 ns±0.92  7689.45ns±21.92  88.21ns±1.69  28.67ns±2.32 
 Group III  BS 15 mg/kg  12.26ns  
±0.87 
 38.35ns±1.36  6.99 ns±0.38  7891.21ns±16.92  81.76ns±1.91  22.65 ns±1.92 
 Group IV  BS 25 mg/kg 12.52ns±1.39 37.98 ns±0.89 6.36 ns±1.23 8123.93ns±18.20 82.32ns±2.23 25.37 ns±1.08 
Duration: 60 d; Values are±SEM; five animals were maintained in each group, Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
 































































































































Duration: 60 d; Values are±SEM; five animals were maintained in each group, Level of significance-ns-non-significant, *p<0.05, **p<0.01, 
***p<0.001, when compared to control 
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Medicinal plants have been utilized as remedies for human diseases 
for a very long time because they incorporate elements of 
therapeutic values [31, 32]. Many drugs like aspirin, 
digoxin, quinine, and opium, etc., used in Medicare are synthesized 
copies of chemicals found naturally in plants or are modified from 
the initial natural product. The population explosion is one of the 
biggest challenges prevalent in the world especially developing 
countries like India, having severe consequences in every aspect of 
development, such as employment, sanitation, and environment, 
education, housing and healthcare [33]. Very few options are 
available for male contraception in comparison to females, having an 
herbal background. This led us to study the pharmacological effect of 
β-sitosterol which is an active component isolated from the roots of 
Barleria prionitis on the male reproductive system. 
During the research endeavor, β-sitosterol was isolated from the 
roots of Barleria prionitis by the soxhlet extraction and silica gel 
chromatography method. Presence of β-sitosterol has been reported 
in various plants, such as areal parts of Ageratum conyzoides [34], 
leaves of Rubus suavissimus [35], fruits of Corylus colurna Linn [36] 
and root bark of Terminalia glaucescens [37] as well as in the tissue 
cultures of Adhatoda vasica and Ageratum conyzoides [38] and cell 
suspension culture of Chrysanthemum coronarium L [39]. 
The results revealed non-significant changes in the body weight and 
vital organ weight (Liver, Adrenal gland, Heart, Kidney) of rats 
treated with β-sitosterol isolated from Barleria prionitis. This 
showed the absence of toxic side effects on the plants. However, a 
significant weight reduction was seen in the reproductive organs i.e. 
testes, caput and caudal epididymis, seminal vesicle, vas deferens, 
prostate and the weight reduction were dose dependent, which is 
known to be mostly related to the number of spermatids and 
spermatozoa present in the tissues. This relationship was also 
concluded by [40-45] in their treatment with various extracts and 
drugs in male albino mice and rats. Reduced availability of androgen 
can be an indirect reason for the weight reduction of these 
reproductive organs [46].  
Thejashwini et al. [47] in their study, which was conducted on 
cyamposis psoralioides in male swiss albino mice concluded that 
testosterone is an important steroidal androgen, plays a central role 
in maturation, spermatogenesis and the maintenance of accessory 
sex organs and Testes. Like other steroid hormones, testosterone is 
also a derivative of cholesterol, which is in the agreement with 
previous studies [48]. β-sitosterol is a primary steroid used in 
traditional medicine, which is structurally similar to cholesterol. So, 
β-sitosterol may inhibit the conversion of cholesterol to testosterone 
by blocking the side chain cleavage of cholesterol by CYP11A 
(a mitochondrial cytochrome P450 oxidase) or any other step of 
testosterone biosynthesis. Therefore, any small change in 
testosterone content may result in the reduction of reproductive 
organs weight. 
Analysis of cauda epididymal fluid of treated rats on hemocytometer 
revealed a significant decrease in the sperm count which might be a 
reflection of the inhibition of spermatogenesis by BS treatment. 
Generation of reactive oxygen species (ROS) that caused oxygen 
stress can be another possibility of low sperm concentration by the 
β-sitosterol treatment. Ghosh et al. [49] also reported about a 
generation of oxidative stress by alpha-tocopherol-succinate 
(provitamin-E) in cyclophosphamide-induced testicular 
gametogenic and steroidogenic disorders. Reduced testicular weight 
and decreased testosterone level may also be one of the reasons for 
the reduction in the sperm count [50]. The present study also 
revealed a significant decrease in sperm motility, which focuses on 
the direct effect of the β-sitosterol on mature and stored sperms in 
Epididymis. Sperm motility may be decreased due to alteration in 
energy metabolism. The sperm axoneme engine requires a 
continuous supply of ATP to maintain motility in the male and 
female reproductive tract. The initiation of the flagellar movement of 
sperm is dependent on the phosphorylation of a contractile protein 
dynein. Brokaw [51] described in their studies that after 
phosphorylation, the dynein ATPase is activated. The energy 
released by the hydrolysis of ATP converted to force, causes the 
microtubules to slide past one another. Interference with enzymatic 
reactions involved in uncoupling of oxidative phosphorylation may 
be a reason for reduced sperm motility by BS treatment. This can 
lead to the incompetence of the spermatozoa to reach the Fallopian 
tubes and fertilize the egg, thus causing sterility [52].  
The sera of animals treated with BS showed a significant decrease in 
the level of assayed gonadotropins (FSH and LH) compared with 
control. This indicated interference in the feedback mechanism 
among hypothalamus, pituitary, and testes. These hormones are 
synthesized and secreted under the influence of Gonadotropin-
releasing hormone (GnRH) from the pituitary gland under the 
control of the hypothalamus. Treatment with BS possibly decreased 
the levels of FSH and LH by inhibiting GnRH. FSH and LH are the key 
enzymes, which trigger the Testosterone biosynthesis from the 
seminiferous tubules. Low levels of these hormones reduced 
testosterone secretion from the Testes by suppressing testicular 
steroidogenesis and spermatogenesis [53] since the pituitary-
testicular axis is a central regulatory unit for the normal functioning 
of the testes and the production of spermatozoa [54]. 
Decreased Levels of Protein, Fructose, Glycogen and Ascorbic acid 
and an increased level of Cholesterol in reproductive organs of 
treated rats, supported physiological changes. The low level of 
Protein in reproductive organs is an indication of inhibition of 
spermatogenesis. Protein is the main component of cell formation, a 
decrease in the Protein content of reproductive organs indicated the 
poor growth rate. The conversion of Cholesterol to Pregnenolone is 
dependent upon pituitary LH/ICSH [55]. Lower availability of these 
hormones restricts this conversion and lead to increase Cholesterol 
content. According to the previous studies of Gonzales et al. [56], 
Fructose, which is a main secretory product from Seminal vesicle 
(SV) provides nutrition to the sperms. Reduction in fructose content 
in Seminal vesicle supported the inhibition of androgen production 
by BS because fructose synthesis in Seminal vesicle is directly 
androgen dependent which can inhibit the sperm motility by a 
deficient generation of ATP.  
This led to the depletion of the nutritional requirements of sperms. 
Significant depletion in glycogen content of the testes by BS 
treatment is possibly due to the inhibition of phosphorylase 
inactivation or the depletion of certain other enzymes which are 
required for glycogenesis. Sertoli cells and spermatogonia contain 
Glycogen and provide nourishments to the seminiferous tubular 
cells and the Glycogen content is found to be directly proportional to 
the steroid hormone levels. A decrease in glycogen content of the 
Testes reduced the energy source for spermatogenic activity, which 
might have resulted in the spermatogenic arrest. Ascorbic acid 
prevents DNA damage induced by scavenging the ROS generated in 
testes [57]. Decreased Ascorbic acid content represents the hypo-
functioning of the Testes and the degeneration of the germinal 
epithelium due to vitamin C deficiency. 
100 % inhibition of fertility was observed in the high dose (25 
mg/kg BW) treated group which was mainly due to reduced 
testosterone level, which might be sufficient for normal mating 
behavior, but insufficient for the maintenance of fertilizing ability of 
the epididymal spermatozoa. 
Non-significant changes in serum biochemical and hematological 
parameters supported non-toxic nature of β-sitosterol. 
CONCLUSION 
In the present study, dose-dependent treatment of β-sitosterol 
isolated from the roots of Barleria prionitis caused marked 
alterations in the male reproductive organs, which were reflected by 
the reduced Testosterone, FSH, LH, sperm motility, sperm density in 
reproductive organs. These effects altogether lead to the 
suppression of the spermatogenesis and finally infertility to the male 
rats. On the basis of these effects, we can conclude that BS has a 
potential to develop a cheap, acceptable, easily available, non-toxic, 
safe, herbal male contraceptive drug. However, further 
pharmacological and molecular studies are needed to find out the 
exact mechanism of action and to investigate whether these 
alterations are reversible or permanent after cessation of the 
treatment. Further studies are planned in this direction. 
Gupta et al. 
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